Analyzing Glucose Health (GLUC) & The Competition

Glucose Health (OTCMKTS:GLUC) is one of 52 public companies in the “Medicinals & botanicals” industry, but how does it weigh in compared to its competitors? We will compare Glucose Health to similar companies based on the strength of its valuation, risk, analyst recommendations, profitability, dividends, earnings and institutional ownership.

Insider and Institutional Ownership

15.8% of shares of all “Medicinals & botanicals” companies are owned by institutional investors. 21.0% of shares of all “Medicinals & botanicals” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Earnings & Valuation

This table compares Glucose Health and its competitors revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Glucose Health	$540,000.00	-$420,000.00	-9.32
Glucose Health Competitors	$316.88 million	-$49.81 million	-8.47

Glucose Health’s competitors have higher revenue, but lower earnings than Glucose Health. Glucose Health is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Volatility & Risk

Glucose Health has a beta of 3.49, indicating that its share price is 249% more volatile than the S&P 500. Comparatively, Glucose Health’s competitors have a beta of 1.20, indicating that their average share price is 20% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Glucose Health and its competitors, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Glucose Health	0	0	0	0	N/A
Glucose Health Competitors	272	554	986	73	2.46

As a group, “Medicinals & botanicals” companies have a potential upside of 46.32%. Given Glucose Health’s competitors higher probable upside, analysts plainly believe Glucose Health has less favorable growth aspects than its competitors.

Profitability

This table compares Glucose Health and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Glucose Health	-75.00%	N/A	N/A
Glucose Health Competitors	-41.35%	-262.13%	-7.80%

Summary

Glucose Health competitors beat Glucose Health on 6 of the 10 factors compared.

About Glucose Health

Glucose Health, Inc. engages in the formulation, manufacturing, marketing, and distribution of soluble fiber infused nutritional beverages. It offers soluble fiber infused powdered iced tea, and flavored drink mixes for pre-diabetic and diabetic persons under the GLUCODOWN brand in North America. The company was formerly known as Bio-Solutions Corp. and changed its name to Glucose Health, Inc. in November 2014. Glucose Health, Inc. was incorporated in 2007 and is based in Bentonville, Arkansas.